for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Knight Therapeutics Announces Approval Of Ibsrela™ In Canada

April 17 (Reuters) - Knight Therapeutics Inc:

* KNIGHT THERAPEUTICS ANNOUNCES APPROVAL OF IBSRELA™ IN CANADA

* KNIGHT THERAPEUTICS - HEALTH CANADA APPROVED IBSRELA FOR TREATMENT OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION IN ADULTS Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up